XML 26 R15.htm IDEA: XBRL DOCUMENT
v3.8.0.1

STOCK OPTIONS | 9 Months Ended
--- | ---
Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
STOCK OPTIONS | STOCK OPTIONS The Company’s 2015 Equity Incentive Plan (the “Plan”) which was adopted by the Company and approved by its shareholders in April 2015, amended and restated the Company’s 2014 Stock Option Plan. The maximum number of shares of common stock that may be issued pursuant to stock-based awards under the Plan equals 1,000,000 shares, all of which may be subject to incentive stock option treatment. Option awards are generally granted with an exercise price equal to the market price of the Company’s common stock at the date of grant. Currently outstanding option awards have vesting periods ranging from 5 to 10 years and have 10-year contractual terms. The fair value of each option award is estimated on the date of grant using a closed form option valuation (Black-Scholes) model that uses the assumptions noted in the table below. Expected volatilities are based on historical volatilities of the Company’s common stock and similar peer group averages. The Company uses historical data to estimate option exercise and post-vesting termination behavior. The expected term of options granted is based on historical data and represents the period of time that options granted are expected to be outstanding, which takes in to account that the options are not transferable. The risk-free interest rate for the expected term of the option is based on U.S. Treasury yield curve in effect at the time of the grant. A summary of activity in the Plan during the nine months ended September 30, 2017 and 2016 follows:
Nine Months Ended September 30, 2017 |  | Number of Shares |  | Weighted-Average Exercise Price |  | Weighted-Average Remaining Contractual Life in Years |  | Aggregate Intrinsic Value
Outstanding at beginning of year |  | 340,377 |  |  | $ | 23.43 |  |  | 7.34 |  | $ | 194 |
Granted |  | 150,598 |  |  | 27.64 |  |  | 9.62 |  | 657 |
Exercised |  | (7,033 | ) |  | 11.94 |  |  | 4.48 |  | 141 |
Forfeited |  | (6,000 | ) |  | 23.17 |  |  | 7.13 |  | 53 |
Balance, September 30, 2017 |  | 477,942 |  |  | $ | 24.93 |  |  | 7.57 |  | $ | 3,376 |
Exercisable at end of period |  | 98,044 |  |  | $ | 23.45 |  |  | 6.17 |  | $ | 838 |
Nine Months Ended September 30, 2016 |  | Number of Shares |  | Weighted-Average Exercise Price |  | Weighted-Average Remaining Contractual Life in Years |  | Aggregate Intrinsic Value
Outstanding at beginning of year |  | 314,391 |  |  | $ | 23.28 |  |  | 8.00 |  | $ | 225 |
Granted |  | 37,500 |  |  | 23.44 |  |  | 9.50 |  | 21 |
Forfeited |  | (19,000 | ) |  | 23.16 |  |  | 8.15 |  | 16 |
Balance, September 30, 2016 |  | 332,891 |  |  | $ | 23.31 |  |  | 7.45 |  | $ | 230 |
Exercisable at end of period |  | 58,491 |  |  | $ | 21.24 |  |  | 6.53 |  | $ | 161 |
A summary of nonvested activity in the Plan during the nine months ended September 30, 2017 and 2016 follows:
Nine Months Ended September 30, 2017 |  | Number of Shares |  | Weighted-Average Exercise Price |  | Weighted-Average Remaining Contractual Life in Years |  | Aggregate Intrinsic Value
Outstanding at beginning of year |  | 250,700 |  |  | $ | 23.73 |  |  | 7.65 |  | $ | 69 |
Granted |  | 150,598 |  |  | 27.64 |  |  | 9.62 |  | 657 |
Vested |  | (17,400 | ) |  | 23.13 |  |  | 7.91 |  | 154 |
Forfeited |  | (4,000 | ) |  | 23.17 |  |  | 7.13 |  | 53 |
Balance, September 30, 2017 |  | 379,898 |  |  | $ | 25.31 |  |  | 7.93 |  | $ | 2,538 |
Nine Months Ended September 30, 2016 |  | Number of Shares |  | Weighted-Average Exercise Price |  | Weighted-Average Remaining Contractual Life in Years |  | Aggregate Intrinsic Value
Outstanding at beginning of year |  | 267,200 |  |  | $ | 23.72 |  |  | 8.22 |  | $ | 76 |
Granted |  | 37,500 |  |  | 23.44 |  |  | 9.50 |  | 21 |
Vested |  | (13,500 | ) |  | 23.00 |  |  | 8.59 |  | 14 |
Forfeited |  | (16,800 | ) |  | 23.16 |  |  | 8.15 |  | 16 |
Balance, September 30, 2016 |  | 274,400 |  |  | $ | 23.75 |  |  | 7.65 |  | $ | 69 |
Information related to the Plan is as follows for the nine months ended:
|  | September 30, 2017
Intrinsic value of options exercised |  | $ | 141 |
Cash received from options exercised |  | 84 |
Tax benefit realized from options exercised |  | — |
Weighted average fair value of options granted |  | 5.40 |
As of September 30, 2017, there was $1,963 of total unrecognized compensation expense related to unvested stock options granted under the Plan. The expense is expected to be recognized over a weighted-average period of 4.43 years. The Company granted options under the Plan during the first nine months of 2016 and 2017. Expense of $247 and $162 was recorded during the nine months ended September 30, 2017 and 2016, respectively.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration